The CXCL12 receptors, CXCR4 and CXCR7, are also overexpressed within GSCs 135, 136, and the CXCR4 inhibitor AMD3100 reduced GSC-mediated tumor growth and angiogenesis in association with lower VEGF production 135. The gene discussed is CXCR4; the disease is neoplasm.